Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Fountzilas, G., Dafni U., Bobos M., Kotoula V., Batistatou A., Xanthakis I., et al. (2013).  Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.. BMC Cancer. 13, 163.
Fountzilas, G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., et al. (2016).  TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.. Oncotarget. 7(22), 32731-53.
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Fountzilas, E., Kotoula V., Tikas I., Manousou K., Papadopoulou K., Poulios C., et al. (2018).  Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.. Oncotarget. 9(86), 35623-35638.
Fountoulakis, K. N., Gonda X., Andreoulakis E., Fokas K., & Iacovides A. (2013).  No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study.. J Psychiatr Res. 47(12), 1984-90.
Fountoulakis, K. N., & Möller H-J. (2011).  Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.. Int J Neuropsychopharmacol. 14(3), 405-12.
Fountoulakis, K. N., Gonda X., Vieta E., & Schmidt F. (2009).  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.. Ann Gen Psychiatry. 8, 27.
Fountoulakis, K. N., Moeller H-J., Kasper S., Tamminga C., Yamawaki S., Kahn R., et al. (2020).  The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia.. CNS Spectr. 1-25.
Fountoulakis, K. N., & Möller H-J. (2012).  Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.. J Psychopharmacol. 26(5), 744-50.
Fountoulakis, K. N., Karavelas V., Moysidou S., Mavridis D., Pastiadis K., Petalidou N., et al. (2019).  Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study.. Pharmacopsychiatry. 52(4), 193-202.
Fountoulakis, K. N. (2020).  Brain Volume Changes Under Treatment With Antipsychotics.. JAMA Psychiatry. 77(8), 876-877.
Fountoulakis, K. N., Panagiotidis P., Kimiskidis V., Nimatoudis I., & Gonda X. (2019).  Neurological soft signs in familial and sporadic schizophrenia.. Psychiatry Res. 272, 222-229.
Fountoulakis, K. N. (2017).  DSM-III-R change in definition might have affected placebo response to antidepressants.. Lancet Psychiatry. 4(1), 21-22.
Fountoulakis, K. N., Balaris D., Nikolaou V., & Νimatoudis J. (2016).  [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].. Psychiatriki. 27(4), 253-263.
Fountoulakis, K. N., Yatham L. N., Grunze H., Vieta E., Young A. H., Blier P., et al. (2020).  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.. Int J Neuropsychopharmacol. 23(4), 230-256.
Fountoulakis, K. N., Panagiotidis P., Gonda X., Kimiskidis V., & Nimatoudis I. (2019).  Corrigendum to "Neurological soft signs significantly differentiate schizophrenia patients from healthy controls"; [Acta Neuropsychiatrica 2018;30(2):97-105].. Acta Neuropsychiatr. 31(1), 61.
Fountoulakis, K. N., Siamouli M., Magiria M., Pantoula E., Moutou K., Kemeridou M., et al. (2014).  Standardization of the TEMPS-A in the Greek general population.. J Affect Disord. 158, 19-29.
Fountoulakis, K. N. (2015).  Treatment guidelines for mental disorders: reality or illusion?. Psychiatriki. 26(2), 89-92.
Fountoulakis, K. N., Panagiotidis P., Theofilidis A. T., & Nimatoudis I. (2020).  One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.. Clin Psychopharmacol Neurosci. 18(3), 434-444.
Fountoulakis, K. N., Pavlidis I., & Tsolaki M. (2011).  Life events and dementia: what is the nature of their relationship?. Psychiatry Res. 190(1), 156-8.
Fountoulakis, K. N. (2012).  Past, present and future in the treatment of major psychotic disorders.. Curr Pharm Des. 18(12), 1557.
Fountoulakis, K. N., Savopoulos C., Zannis P., Apostolopoulou M., Fountoukidis I., Kakaletsis N., et al. (2016).  Climate change but not unemployment explains the changing suicidality in Thessaloniki Greece (2000-2012).. J Affect Disord. 193, 331-8.
Fountoulakis, K. N., & Souliotis K. (2019).  The right to choose treatment-without-treatment: respecting civil rights or an unprecedented manifestation of 'reverse stigma'?. Acta Neuropsychiatr. 31(1), 56-58.
Fountoulakis, K. N. (2010).  Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'.. Ann Gen Psychiatry. 9, 3.
Fountoulakis, K. N., Vieta E., & Schmidt F. (2011).  Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.. J Affect Disord. 133(3), 361-70.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές